Do people who choose their treatment in a large randomised trial with parallel preference groups differ at baseline from those who agree to random treatment allocation? Results from the protect study

被引:1
|
作者
Mills, Nicola [1 ]
Khazragui, Hanan [1 ]
Metcalfe, Chris [1 ]
Lane, Athene [1 ]
Davis, Michael [1 ]
Young, Grace [1 ]
Neal, David [2 ]
Hamdy, Freddie [3 ]
Donovan, Jenny [1 ]
机构
[1] Univ Bristol, Bristol, Avon, England
[2] Univ Cambridge, Cambridge, England
[3] Univ Oxford, Oxford, England
来源
TRIALS | 2015年 / 16卷
关键词
Prostate Cancer; Randomise Trial; External Validity; Treatment Preference; Clinical Measure;
D O I
10.1186/1745-6215-16-S2-P109
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
P109
引用
收藏
页数:1
相关论文
共 21 条
  • [1] Do people who choose their treatment in a large randomised trial with parallel preference groups differ at baseline from those who agree to random treatment allocation? Results from the protect study
    Nicola Mills
    Hanan Khazragui
    Chris Metcalfe
    Athene Lane
    Michael Davis
    Grace Young
    David Neal
    Freddie Hamdy
    Jenny Donovan
    Trials, 16
  • [2] Do obese patients who choose bariatric surgery differ in clinical characteristics, eating disorders or psychopathology from those who choose traditional treatment?
    Wiren, Mikael
    Elfhag, K.
    Konradsson, L.
    OBESITY SURGERY, 2007, 17 (08) : 1028 - 1029
  • [3] How do good candidates for trial of labor after cesarean (TOLAC) who undergo elective repeat cesarean differ from those who choose TOLAC?
    Metz, Torri D.
    Stoddard, Gregory J.
    Henry, Erick
    Jackson, Marc
    Holmgren, Calla
    Esplin, Sean
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (06) : 458.e1 - 458.e6
  • [4] Do STD clinic patients who consent to sexual health research differ from those who decline? Findings from a randomized controlled trial with implications for the generalization of research results
    Carey, Michael P.
    Senn, Theresa E.
    Vanable, Peter A.
    Coury-Doniger, Patricia
    Urban, Marguerite A.
    SEXUALLY TRANSMITTED DISEASES, 2008, 35 (01) : 73 - 77
  • [5] SlowMo, a digital therapy targeting reasoning in paranoia, versus treatment as usual in the treatment of people who fear harm from others: study protocol for a randomised controlled trial
    Philippa A. Garety
    Thomas Ward
    Daniel Freeman
    David Fowler
    Richard Emsley
    Graham Dunn
    Elizabeth Kuipers
    Paul Bebbington
    Helen Waller
    Kathryn Greenwood
    Mar Rus-Calafell
    Alison McGourty
    Amy Hardy
    Trials, 18
  • [6] SlowMo, a digital therapy targeting reasoning in paranoia, versus treatment as usual in the treatment of people who fear harm from others: study protocol for a randomised controlled trial
    Garety, Philippa A.
    Ward, Thomas
    Freeman, Daniel
    Fowler, David
    Emsley, Richard
    Dunn, Graham
    Kuipers, Elizabeth
    Bebbington, Paul
    Waller, Helen
    Greenwood, Kathryn
    Rus-Calafell, Mar
    McGourty, Alison
    Hardy, Amy
    TRIALS, 2017, 18
  • [7] Community-based hepatitis C treatment of people who inject drugs and their injecting network is feasible and effective: Results from the TAP (Treatment And Prevention) study
    Doyle, Joseph
    Dietze, Paul
    Stoove, Mark
    Higgs, Peter
    Desmond, Paul
    Iser, David
    Mcbryde, Emma
    Harney, Brendan
    Pedrana, Alisa
    Spelman, Tim
    Von Bibra, Sally
    Roney, Janine
    Thompson, Alexander
    Hellard, Margaret
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E495 - E495
  • [8] Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study
    Roux, Perrine
    Faye, Aissatou
    Sagaon-Teyssier, Luis
    Donadille, Cecile
    Madrid, Laelia Briand
    Carrieri, Maria Patrizia
    Maradan, Gwenaelle
    Jauffret-Roustide, Marie
    Lalanne, Laurence
    Auriacombe, Marc
    DRUG AND ALCOHOL REVIEW, 2025, 44 (01) : 275 - 287
  • [9] Non hospitalised stroke patients: Who are they and what treatment do they receive? Final Results from the North East Melbourne Stroke Incidence Study (NEMESIS)
    Gilligan, AK
    Thrift, AG
    Sturm, JW
    Dewey, HM
    Macdonell, RAL
    Donnan, GA
    STROKE, 2004, 35 (06) : E287 - E287
  • [10] The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usual
    Gilchrist, Gail
    Swan, Davina
    Shaw, April
    Keding, Ada
    Towers, Sarah
    Craine, Noel
    Munro, Alison
    Hughes, Elizabeth
    Parrott, Steve
    Strang, John
    Taylor, Avril
    Watson, Judith
    HARM REDUCTION JOURNAL, 2017, 14